Correlation Between Avicanna and HLS Therapeutics
Can any of the company-specific risk be diversified away by investing in both Avicanna and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avicanna and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avicanna and HLS Therapeutics, you can compare the effects of market volatilities on Avicanna and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avicanna with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avicanna and HLS Therapeutics.
Diversification Opportunities for Avicanna and HLS Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Avicanna and HLS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Avicanna and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Avicanna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avicanna are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Avicanna i.e., Avicanna and HLS Therapeutics go up and down completely randomly.
Pair Corralation between Avicanna and HLS Therapeutics
Assuming the 90 days horizon Avicanna is expected to generate 2.26 times more return on investment than HLS Therapeutics. However, Avicanna is 2.26 times more volatile than HLS Therapeutics. It trades about 0.07 of its potential returns per unit of risk. HLS Therapeutics is currently generating about 0.09 per unit of risk. If you would invest 20.00 in Avicanna on December 26, 2024 and sell it today you would earn a total of 3.00 from holding Avicanna or generate 15.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 93.33% |
Values | Daily Returns |
Avicanna vs. HLS Therapeutics
Performance |
Timeline |
Avicanna |
HLS Therapeutics |
Avicanna and HLS Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Avicanna and HLS Therapeutics
The main advantage of trading using opposite Avicanna and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avicanna position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.Avicanna vs. Pharmacielo | Avicanna vs. Khiron Life Sciences | Avicanna vs. Flower One Holdings | Avicanna vs. Cansortium |
HLS Therapeutics vs. Aion Therapeutic | HLS Therapeutics vs. Cannara Biotech | HLS Therapeutics vs. Knight Therapeutics | HLS Therapeutics vs. Canntab Therapeutics Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |